Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

Original Article: Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

More From BioPortfolio on "Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab"